Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
[Contrast nephropathy and its prevention].

Vnitrni lekarstvi

Skulec R, Bĕlohlávek J, Kovárník T, Linhart A, Aschermann M.
PMID: 12728580
Vnitr Lek. 2003 Feb;49(2):127-33.

Contrast-induced nephropathy is one of the adverse events of diagnostic and therapeutic intravascular application of contrast agent. In general, the condition was defined as an increase in the serum creatinine concentration of more than 44 mmol/l or of more...

Cite
Skulec R, Bĕlohlávek J, Kovárník T, et al. Kontrastová nefropatie a moznosti její prevence. [Contrast nephropathy and its prevention]. Vnitr Lek. 2003;49(2):127-33
Skulec, R., Bĕlohlávek, J., Kovárník, T., Linhart, A., & Aschermann, M. (2003). Kontrastová nefropatie a moznosti její prevence. [Contrast nephropathy and its prevention]. Vnitrni lekarstvi, 49(2), 127-33.
Skulec, R, et al. "Kontrastová nefropatie a moznosti její prevence." [Contrast nephropathy and its prevention]. Vnitrni lekarstvi vol. 49,2 (2003): 127-33.
Skulec R, Bĕlohlávek J, Kovárník T, Linhart A, Aschermann M. Kontrastová nefropatie a moznosti její prevence. [Contrast nephropathy and its prevention]. Vnitr Lek. 2003 Feb;49(2):127-33. Czech. PMID: 12728580.
Copy Download .nbib Format: NLM
Prophylaxis strategies for contrast-induced nephropathy.

JAMA

Pannu N, Wiebe N, Tonelli M.
PMID: 16788132
JAMA. 2006 Jun 21;295(23):2765-79. doi: 10.1001/jama.295.23.2765.

CONTEXT: Contrast-induced nephropathy is associated with significant economic and clinical consequences, including prolonged hospitalization, the requirement for dialysis, and an increased risk of death.OBJECTIVES: To summarize the current state of evidence for prophylaxis of contrast-induced nephropathy, provide evidence-based recommendations...

Cite
Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295(23):2765-79doi: 10.1001/jama.295.23.2765.
Pannu, N., Wiebe, N., Tonelli, M. (2006). Prophylaxis strategies for contrast-induced nephropathy. JAMA, 295(23), 2765-79. https://doi.org/10.1001/jama.295.23.2765
Pannu, Neesh, et al. "Prophylaxis strategies for contrast-induced nephropathy." JAMA vol. 295,23 (2006): 2765-79. doi: https://doi.org/10.1001/jama.295.23.2765
Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006 Jun 21;295(23):2765-79. doi: 10.1001/jama.295.23.2765. PMID: 16788132.
Copy Download .nbib Format: NLM
Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients.

BMC anesthesiology

Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR.
PMID: 18837982
BMC Anesthesiol. 2008 Oct 06;8:6. doi: 10.1186/1471-2253-8-6.

BACKGROUND: Fenoldopam mesylate, a selective dopamine1-receptor agonist, is used by intravenous infusion to treat hypertension in adults. Fenoldopam is not approved by the FDA for use in children; reports describing its use in pediatrics are limited. In a multi-institutional,...

Cite
Hammer GB, Verghese ST, Drover DR, et al. Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients. BMC Anesthesiol. 2008;8:6doi: 10.1186/1471-2253-8-6.
Hammer, G. B., Verghese, S. T., Drover, D. R., Yaster, M., & Tobin, J. R. (2008). Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients. BMC anesthesiology, 86. https://doi.org/10.1186/1471-2253-8-6
Hammer, Gregory B, et al. "Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients." BMC anesthesiology vol. 8 (2008): 6. doi: https://doi.org/10.1186/1471-2253-8-6
Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR. Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients. BMC Anesthesiol. 2008 Oct 06;8:6. doi: 10.1186/1471-2253-8-6. PMID: 18837982; PMCID: PMC2576052.
Copy Download .nbib Format: NLM
Management of hypertensive crises in the elderly.

Journal of geriatric cardiology : JGC

Alshami A, Romero C, Avila A, Varon J.
PMID: 30364798
J Geriatr Cardiol. 2018 Jul;15(7):504-512. doi: 10.11909/j.issn.1671-5411.2018.07.007.

Hypertensive crises are elevations of blood pressure higher than 180/120 mmHg. These can be urgent or emergent, depending on the presence of end organ damage. The clinical presentation of hypertensive crises is quite variable in elderly patients, and clinicians...

Cite
Alshami A, Romero C, Avila A, et al. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15(7):504-512doi: 10.11909/j.issn.1671-5411.2018.07.007.
Alshami, A., Romero, C., Avila, A., & Varon, J. (2018). Management of hypertensive crises in the elderly. Journal of geriatric cardiology : JGC, 15(7), 504-512. https://doi.org/10.11909/j.issn.1671-5411.2018.07.007
Alshami, Abbas, et al. "Management of hypertensive crises in the elderly." Journal of geriatric cardiology : JGC vol. 15,7 (2018): 504-512. doi: https://doi.org/10.11909/j.issn.1671-5411.2018.07.007
Alshami A, Romero C, Avila A, Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018 Jul;15(7):504-512. doi: 10.11909/j.issn.1671-5411.2018.07.007. PMID: 30364798; PMCID: PMC6198269.
Copy Download .nbib Format: NLM
Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes.

Biochemical and biophysical research communications

Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y.
PMID: 34953210
Biochem Biophys Res Commun. 2022 Jan 15;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18.

Adipocytes express several kinds of catecholamine receptors, including adrenergic receptors, and dopamine receptors. Signaling pathways mediated by catecholamine receptors, such as β3-adrenergic receptor pathway, can induce body energy expenditure via activating thermogenesis of adipose tissue. However, the roles of...

Cite
Yu J, Zhu J, Deng J, et al. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021;588:83-89doi: 10.1016/j.bbrc.2021.12.040.
Yu, J., Zhu, J., Deng, J., Shen, J., Du, F., Wu, X., Chen, Y., Li, M., Wen, Q., Xiao, Z., & Zhao, Y. (2022). Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochemical and biophysical research communications, 58883-89. https://doi.org/10.1016/j.bbrc.2021.12.040
Yu, Jing, et al. "Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes." Biochemical and biophysical research communications vol. 588 (2022): 83-89. doi: https://doi.org/10.1016/j.bbrc.2021.12.040
Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2022 Jan 15;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18. PMID: 34953210.
Copy Download .nbib Format: NLM
Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes.

Biochemical and biophysical research communications

Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y.
PMID: 34953210
Biochem Biophys Res Commun. 2021 Dec 18;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18.

Adipocytes express several kinds of catecholamine receptors, including adrenergic receptors, and dopamine receptors. Signaling pathways mediated by catecholamine receptors, such as β3-adrenergic receptor pathway, can induce body energy expenditure via activating thermogenesis of adipose tissue. However, the roles of...

Cite
Yu J, Zhu J, Deng J, et al. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021;588:83-89doi: 10.1016/j.bbrc.2021.12.040.
Yu, J., Zhu, J., Deng, J., Shen, J., Du, F., Wu, X., Chen, Y., Li, M., Wen, Q., Xiao, Z., & Zhao, Y. (2021). Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochemical and biophysical research communications, 58883-89. https://doi.org/10.1016/j.bbrc.2021.12.040
Yu, Jing, et al. "Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes." Biochemical and biophysical research communications vol. 588 (2021): 83-89. doi: https://doi.org/10.1016/j.bbrc.2021.12.040
Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021 Dec 18;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18. PMID: 34953210.
Copy Download .nbib Format: NLM
Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes.

Biochemical and biophysical research communications

Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y.
PMID: 34953210
Biochem Biophys Res Commun. 2021 Dec 18;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18.

Adipocytes express several kinds of catecholamine receptors, including adrenergic receptors, and dopamine receptors. Signaling pathways mediated by catecholamine receptors, such as β3-adrenergic receptor pathway, can induce body energy expenditure via activating thermogenesis of adipose tissue. However, the roles of...

Cite
Yu J, Zhu J, Deng J, et al. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021;588:83-89doi: 10.1016/j.bbrc.2021.12.040.
Yu, J., Zhu, J., Deng, J., Shen, J., Du, F., Wu, X., Chen, Y., Li, M., Wen, Q., Xiao, Z., & Zhao, Y. (2021). Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochemical and biophysical research communications, 58883-89. https://doi.org/10.1016/j.bbrc.2021.12.040
Yu, Jing, et al. "Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes." Biochemical and biophysical research communications vol. 588 (2021): 83-89. doi: https://doi.org/10.1016/j.bbrc.2021.12.040
Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021 Dec 18;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18. PMID: 34953210.
Copy Download .nbib Format: NLM
Contrast nephropathy in children.

Journal of pediatric intensive care

Verghese PS.
PMID: 31214451
J Pediatr Intensive Care. 2014 Jun;3(2):45-52. doi: 10.3233/PIC-14090.

Contrast-induced nephropathy (CIN) remains a common and potentially serious complication in at risk patients after exposure to contrast agents. Risk factors for CIN include chronic kidney disease, hypotension, diabetes mellitus, recent previous exposure to contrast and all of these...

Cite
Verghese PS. Contrast nephropathy in children. J Pediatr Intensive Care. 2014;3(2):45-52doi: 10.3233/PIC-14090.
Verghese, P. S. (2014). Contrast nephropathy in children. Journal of pediatric intensive care, 3(2), 45-52. https://doi.org/10.3233/PIC-14090
Verghese, Priya S. "Contrast nephropathy in children." Journal of pediatric intensive care vol. 3,2 (2014): 45-52. doi: https://doi.org/10.3233/PIC-14090
Verghese PS. Contrast nephropathy in children. J Pediatr Intensive Care. 2014 Jun;3(2):45-52. doi: 10.3233/PIC-14090. PMID: 31214451; PMCID: PMC6530746.
Copy Download .nbib Format: NLM
Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials.

Journal of clinical medicine

Chen WC, Lin MH, Chen CL, Chen YC, Chen CY, Lin YC, Hung CC.
PMID: 33802296
J Clin Med. 2021 Mar 03;10(5). doi: 10.3390/jcm10051032.

Several kinds of inotropes have been used in critically ill patients to improve hemodynamics and renal dysfunction after cardiac surgery; however, the treatment strategies for reducing mortality and increasing renal protection in patients who underwent cardiac surgery remain controversial....

Cite
Chen WC, Lin MH, Chen CL, et al. Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2021;10(5)doi: 10.3390/jcm10051032.
Chen, W. C., Lin, M. H., Chen, C. L., Chen, Y. C., Chen, C. Y., Lin, Y. C., & Hung, C. C. (2021). Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials. Journal of clinical medicine, 10(5), . https://doi.org/10.3390/jcm10051032
Chen, Wei-Cheng, et al. "Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials." Journal of clinical medicine vol. 10,5 (2021). doi: https://doi.org/10.3390/jcm10051032
Chen WC, Lin MH, Chen CL, Chen YC, Chen CY, Lin YC, Hung CC. Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2021 Mar 03;10(5). doi: 10.3390/jcm10051032. PMID: 33802296; PMCID: PMC7959132.
Copy Download .nbib Format: NLM
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.

European journal of medicinal chemistry

Song Y, Zhang H, Yang X, Shi Y, Yu B.
PMID: 34915312
Eur J Med Chem. 2021 Dec 06;228:114042. doi: 10.1016/j.ejmech.2021.114042. Epub 2021 Dec 06.

Lysine-specific demethylase 1 (LSD1/KDM1A) has emerged as a promising epigenetic target for disease treatment. Several LSD1 inhibitors have advanced into clinical trials. Following our last annual review on LSD1 inhibitors in 2020 (Eur. J. Med. Chem. 2021, 214, 113254),...

Cite
Song Y, Zhang H, Yang X, et al. Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021. Eur J Med Chem. 2021;228:114042doi: 10.1016/j.ejmech.2021.114042.
Song, Y., Zhang, H., Yang, X., Shi, Y., & Yu, B. (2021). Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021. European journal of medicinal chemistry, 228114042. https://doi.org/10.1016/j.ejmech.2021.114042
Song, Yihui, et al. "Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021." European journal of medicinal chemistry vol. 228 (2021): 114042. doi: https://doi.org/10.1016/j.ejmech.2021.114042
Song Y, Zhang H, Yang X, Shi Y, Yu B. Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021. Eur J Med Chem. 2021 Dec 06;228:114042. doi: 10.1016/j.ejmech.2021.114042. Epub 2021 Dec 06. PMID: 34915312.
Copy Download .nbib Format: NLM
Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes.

Biochemical and biophysical research communications

Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y.
PMID: 34953210
Biochem Biophys Res Commun. 2021 Dec 18;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18.

Adipocytes express several kinds of catecholamine receptors, including adrenergic receptors, and dopamine receptors. Signaling pathways mediated by catecholamine receptors, such as β3-adrenergic receptor pathway, can induce body energy expenditure via activating thermogenesis of adipose tissue. However, the roles of...

Cite
Yu J, Zhu J, Deng J, et al. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021;588:83-89doi: 10.1016/j.bbrc.2021.12.040.
Yu, J., Zhu, J., Deng, J., Shen, J., Du, F., Wu, X., Chen, Y., Li, M., Wen, Q., Xiao, Z., & Zhao, Y. (2021). Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochemical and biophysical research communications, 58883-89. https://doi.org/10.1016/j.bbrc.2021.12.040
Yu, Jing, et al. "Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes." Biochemical and biophysical research communications vol. 588 (2021): 83-89. doi: https://doi.org/10.1016/j.bbrc.2021.12.040
Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Wen Q, Xiao Z, Zhao Y. Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes. Biochem Biophys Res Commun. 2021 Dec 18;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18. PMID: 34953210.
Copy Download .nbib Format: NLM
Periferic intravenous infusion of fenoldopam through an elastomeric pump.

HSR proceedings in intensive care & cardiovascular anesthesia

Quaranta T, Cornaggia G, Turi S, Mizzi A, Zangrillo A.
PMID: 23439887
HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):54-9.

INTRODUCTION: Fenoldopam has been used to protect renal function in critically ill patients and in those undergoing major surgery, where a possible damage of kidney is expected. Numerous randomized studies and meta-analysis demonstrated the efficacy of fenoldopam in this...

Cite
Quaranta T, Cornaggia G, Turi S, et al. Periferic intravenous infusion of fenoldopam through an elastomeric pump. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):54-9
Quaranta, T., Cornaggia, G., Turi, S., Mizzi, A., & Zangrillo, A. (2009). Periferic intravenous infusion of fenoldopam through an elastomeric pump. HSR proceedings in intensive care & cardiovascular anesthesia, 1(3), 54-9.
Quaranta, T, et al. "Periferic intravenous infusion of fenoldopam through an elastomeric pump." HSR proceedings in intensive care & cardiovascular anesthesia vol. 1,3 (2009): 54-9.
Quaranta T, Cornaggia G, Turi S, Mizzi A, Zangrillo A. Periferic intravenous infusion of fenoldopam through an elastomeric pump. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):54-9. PMID: 23439887; PMCID: PMC3484550.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries